This approval marks Bimzelx as the first and only approved medication that specifically targets and inhibits both interleukin (IL)-17A and IL-17F cytokines, which are believed to play a role in the inflammation associated with HS
For eligible patients, semaglutide can be an effective adjunct to a healthy lifestyle, supporting both metabolic health and weight reduction when combined with diet and exercise
Nicolas Chevalier
Timing Follow-up Marker A1c Why it matters Tracks longer-term glucose control because GH-axis changes may affect insulin sensitivity
The best outcomes come from starting low, tracking how you feel, and having an honest relationship with a healthcare provider who knows what you're taking
It has phase 3 efficacy, published maintenance data, an established safety label, and real-world availability the full package that supports actual clinical decisions